Advertisement
Advertisement
HALO
Halozyme Therapeutics, Inc.
67.64
USDSponsored
+0.33
+0.49%
Apr 15, 14:54 UTC -4
Open
Halozyme Therapeutics, Inc. Financial Snapshot
| Market Cap | 8.01B |
| Beta | 1.03 |
| Earnings Per Share (EPS) | 2.49 |
| Price-to-Book (P/B) Ratio | 161.60 |
| Operating Margin | 33.33% |
| Total Debt/Equity (D/E) | 4389.38% |
| P/E Ratio | 17.75 |
| Return on Equity (ROE) | 136.12% |
| Current Ratio | 4.66% |
| Free Cash Flow | 644.59M |
Trending Stocks
Advertisement